Protas, Oxford and Boehringer Ingelheim partner on major kidney disease trial
Protas is proud to support a new clinical trial among people with chronic kidney disease.
The latest in smarter trials
As a not-for-profit, our mission is to enable whole-system change in clinical trials. This means sharing our approach and knowledge with our community. From news about Protas, our partnerships and trials, to advice and guidance, discover more about our world.
Protas partner Slalom recognised for work on Cantata trial platform
Protas is proud to hear that Slalom has won a Salesforce award for innovation.
Video: Protas supports US community research with Milken Institute
ENRICH-CT is enabling more inclusive clinical research in the US, supported by Protas.
Video: Transform health research by democratising clinical trials
Protas joins colleagues at Milken Institute Global Conference to discuss democratic clinical trials.
Protas collaborates with GSK to advise on optimising protocol development
Protas will advise GSK on clinical trial protocols across a range of late-phase investigational products.
Video: On stage at JP Morgan Healthcare Conference
Prof Sir Martin Landray joins Salesforce and Slalom to talk about our collaboration in revolutionising clinical trials.
Smarter clinical trials for a healthier population
Prof Sir Martin Landray writes about how clinical trials are key to common disease prevention, early detection and treatment.
Tackling common disease burden through clinical trial innovation
As part of New Scientist’s 2023 campaign on innovation in clinical research and development, Prof Sir Martin Landray explores the pressing need to transform clinical…
Protas gains ISO 9001 certification for high standards of quality
The international accreditation acknowledges our approach to quality.
Meet the team: Abbie Gerard, Clinical Quality Assurance Specialist
Abbie Gerard shares what motivated her to move from academia to a new not-for-profit.
Apollo Therapeutics and Protas partner to advance therapeutic programmes
Protas will provide expertise to the portfolio biopharma on a range of drug development programmes.
Meet the board: Esther Krofah
The Executive Vice President of Milken Institute Health shares what drew her to Protas.